2020

NEWS RELEASE
September 21, 2020 – Scenic Biotech Enters into Genetic Modifier Collaboration with Genentech
Read More

ANNOUNCEMENT
September 15, 2020 – Scenic founders publish paper in Science Signaling
Read more

NEWS RELEASE
July 1, 2020 – Scenic Biotech Appoints Oscar Izeboud as Chief Executive Officer
Read more

NEWS RELEASE
June 23, 2020 – Scenic Biotech Awarded €3.1 million Innovation Credit from Dutch Government to Progress CD47/QPCTL Immuno-oncology Program
Read more

COVERAGE
February 5, 2020 – Interview with Scenic’s founder Thijn Brummelkamp in Labiotech
Read more

2019

ANNOUNCEMENT
June 16, 2019 – Scenic’s platform technology patent receives notice of allowance
Read more

ANNOUNCEMENT
March 3, 2019 – Scenic’s advisor Ton Schumacher identifies a modifier of the CD47 “don’t eat me” checkpoint
Read more

ANNOUNCEMENT
January 16, 2019 – Eurostars Grant awarded to Scenic
Read more

2018

ANNOUNCEMENT
June 25, 2018 – Scenic appoints Ulrich Grau as Chairman of the Board
Read more

COVERAGE
April 5, 2018 – Scenic Biotech is named academic spinout of 2017 by Nature Biotechnology
Read more

2017

ANNOUNCEMENT
December 14, 2017 – Scenic appoints Chas Bountra to it’s scientific advisory board
Read more

ANNOUNCEMENT
November 30, 2017 – Scenic appoints Alexandra Glucksmann as member of its Board of Directors
Read more

ANNOUNCEMENT
August 16, 2017 – Scenic’s co-founder Thijn Brummelkamp and advisor Ton Schumacher report identification of a PD-L1 modifier in Nature
Read more

ANNOUNCEMENT
October 17, 2017 – Scenic appoints Stephen Friend and Ton Schumacher to it’s scientific advisory board
Read more

NEWS RELEASE
May 6, 2017 – Scenic Biotech closes financing round
Read more